title: The cost of modern technology.
abstract: Continuous infusion of intravenous (i.v.) drugs is increasing in popularity, as technological advances in equipment (such as "smart" pumps) and pharmacologic improvements of drugs (such as ultra-short acting drugs) are introduced into clinical anesthesia practice. Such new technology, however, also introduces potential new complications. We report one such complication associated with the improper manufacturing of a proprietary i.v. tubing and cassette system.
authors.affiliation: Department of Anesthesiology, Yale University School of Medicine, New Haven, CT 06510, USA.
authors.forename: D
authors.initials: D
authors.lastname: Kelly
authors.forename: S J
authors.initials: SJ
authors.lastname: Brull
mesh_terms: D000771:Anesthesia, Intravenous / Q000009:adverse effects / Q000295:instrumentation*; D001769:Blood; D003365:Costs and Cost Analysis; D004867:Equipment Design; D004868:Equipment Failure; D006801:Humans; D007260:Infusion Pumps / Q000009:adverse effects; D007262:Infusions, Intravenous / Q000009:adverse effects / Q000295:instrumentation; D007440:Intubation / Q000009:adverse effects / Q000295:instrumentation; D008297:Male; D013677:Medical Laboratory Science / Q000191:economics; D008875:Middle Aged; D009599:Nitroprusside / Q000008:administration & dosage
chemical_list: D009599:Nitroprusside